Variant GADL1 and response to lithium in bipolar I disorder[2]

New England Journal of Medicine

Volumn 370, Issue 19, 2014, Pages 1856-1857

  Ikeda, Masashi ^a   Kondo, Kenji ^a   Iwata, Nakao ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM; CARBOXYLYASE; TRANQUILIZER;

BIPOLAR I DISORDER; DRUG RESPONSE; GADL1 GENE; GENE; GENETIC VARIABILITY; GENOTYPE; HUMAN; LETTER; PHARMACOGENETICS; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; BIPOLAR DISORDER; FEMALE; GENETICS; MALE; NOTE;

ANTIMANIC AGENTS; BIPOLAR DISORDER; CARBOXY-LYASES; FEMALE; HUMANS; LITHIUM; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84899822072     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1401817     Document Type: Letter

References (2)

1. Grof P, Duffy A, Cavazzoni P, et al. Is response to prophylactic lithium a familial trait? J Clin Psychiatry 2002;63:942-7. (Pubitemid 35231736)
2. Dupont WD, Plummer WD Jr. Power and sample size calculations for studies involving linear regression. Control Clin Trials 1998;19:589-601. (Pubitemid 29057724)